J&J Hit With $1.75M Verdict In 4th Philly Risperdal Case
A Johnson & Johnson unit was slapped with a $1.75 million verdict in Pennsylvania state court on Monday in a fourth case alleging the company failed to properly disclose the risks...To view the full article, register now.
Already a subscriber? Click here to view full article